Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies

Abstract

Prostate-specific antigen (PSA) is used to screen for prostate disease, although it has several limitations in its application as an organ-specific or cancer-specific marker. Furthermore, a highly specific/sensitive and/or label-free identification of PSA still remains a challenge in the diagnosis of prostate anomalies. We aimed to develop a gold nanoparticle (GNP)-conjugated anti-PSA antibody-based localized surface plasmon resonance (LSPR) as a novel approach to detect prostatic disease. A total of 25 nm colloidal gold particles were prepared followed by conjugation with anti-PSA pAb (GNPs–PSA pAb). LSPR was used to monitor the absorption changes of the aggregation of the particles. The size, shape and stability of the GNP-anti-PSA were evaluated by dynamic light scattering transmission electron microscopy (TEM) and zetasizer. The GNPs-conjugated PSA-pAb was successfully synthesized and subsequently characterized using ultraviolet absorption spectroscopy and TEM to determine the size distribution, crystallinity and stability of the particles (for example, stability of GNP: 443 mV). To increase the stability of the particles, we pegylated GNPs using an N-(3-dimethylaminopropyl)-N*-ethylcarbodiimide hydrochloride (EDC)/N-hydroxylsuccinimide (NHS) linker (for example, stability of GNP after pegylation: 272 mV). We found a significant increase in the absorbance and intensity of the particles with extinction peak at 545/2 nm, which was shifted by ~1 nm after conjugation. To illustrate the potential of the GNPs–PSA pAb to bind specifically to PSA, LSPR was used. We found that the extinction peak shifted 3 nm for a solution of 100 nM unlabeled antigen. In summary, we have established a novel approach for improving the efficacy/sensitivity of PSA in the assessment of prostate disease, supporting further investigation on the diagnostic value of GNP-conjugated anti-PSA/LSPR for the detection of prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B et al. The case for early detection. Nat Rev Cancer 2003; 3: 243–252.

    Article  CAS  Google Scholar 

  2. Srinivas PR, Kramer BS, Srivastava S . Trends in biomarker research for cancer detection. Lancet Oncol 2001; 2: 698–704.

    Article  CAS  Google Scholar 

  3. Zheng G, Patolsky F, Cui Y, Wang WU, Lieber CM . Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat Biotechnol 2005; 23: 1294–1301.

    Article  CAS  Google Scholar 

  4. Jedinak A, Curatolo A, Zurakowski D, Dillon S, Bhasin MK, Libermann TA et al. Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer. BMC Cancer 2015; 15: 1.

    Article  CAS  Google Scholar 

  5. De Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011; 364: 1995–2005.

    Article  CAS  Google Scholar 

  6. Liu X, Dai Q, Austin L, Coutts J, Knowles G, Zou J et al. A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J Am Chem Soc 2008; 130: 2780–2782.

    Article  CAS  Google Scholar 

  7. Endo T, Kerman K, Nagatani N, Hiepa HM, Kim D-K, Yonezawa Y et al. Multiple label-free detection of antigen-antibody reaction using localized surface plasmon resonance-based core-shell structured nanoparticle layer nanochip. Anal Chem 2006; 78: 6465–6475.

    Article  CAS  Google Scholar 

  8. Boniol M, Autier P, Perrin P, Boyle P . Variation of prostate-specific antigen value in men and risk of high-grade prostate cancer: analysis of the prostate, lung, colorectal, and ovarian cancer screening trial study. Urology 2015; 85: 1117–1122.

    Article  Google Scholar 

  9. Miano R, Mele G, Germani S, Bove P, Sansalone S, Pugliese P et al. Evaluation of a new, rapid, qualitative, one-step PSA Test for prostate cancer screening: the PSA RapidScreen test. Prostate Cancer Prostatic Dis 2005; 8: 219–223.

    Article  CAS  Google Scholar 

  10. Kumari GR, Malati T . Stability of total and free prostate specific antigen in serum samples at different storage conditions. Indian J Clin Biochem 2004; 19: 10–13.

    Article  CAS  Google Scholar 

  11. Luo X, Morrin A, Killard AJ, Smyth MR . Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis 2006; 18: 319–326.

    Article  CAS  Google Scholar 

  12. Chumbimuni-Torres KY, Dai Z, Rubinova N, Xiang Y, Pretsch E, Wang J et al. Potentiometric biosensing of proteins with ultrasensitive ion-selective microelectrodes and nanoparticle labels. J Am Chem Soc 2006; 128: 13676–13677.

    Article  CAS  Google Scholar 

  13. Halpern AR, Wood JB, Wang Y, Corn RM . Single-nanoparticle near-infrared surface plasmon resonance microscopy for real-time measurements of DNA hybridization adsorption. ACS nano 2013; 8: 1022–1030.

    Article  Google Scholar 

  14. Kumar A, Boruah BM, Liang X-J . Gold nanoparticles: promising nanomaterials for the diagnosis of cancer and HIV/AIDS. J Nanomater 2011; 2011: 22.

    Google Scholar 

  15. Sepúlveda B, Angelomé PC, Lechuga LM, Liz-Marzán LM . LSPR-based nanobiosensors. Nano Today 2009; 4: 244–251.

    Article  Google Scholar 

  16. Willets KA, Van Duyne RP . Localized surface plasmon resonance spectroscopy and sensing. Annu Rev Phys Chem 2007; 58: 267–297.

    Article  CAS  Google Scholar 

  17. Brolo AG . Plasmonics for future biosensors. Nat Photon 2012; 6: 709–713.

    Article  CAS  Google Scholar 

  18. Frens G . Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature 1973; 241: 20–22.

    CAS  Google Scholar 

  19. Jazayeri MH, Amani H, Pourfatollah AA, Pazoki-Toroudi H, Sedighimoghaddam B . Various methods of gold nanoparticles (GNPs) conjugation to antibodies. Sens BioSensing Res 2016; 9: 17–22.

    Article  Google Scholar 

  20. Amendola V . Surface plasmon resonance of silver and gold nanoparticles in the proximity of graphene studied using the discrete dipole approximation method. Phys Chem Chem Phys 2016; 18: 2230–2241.

    Article  CAS  Google Scholar 

  21. Mousavi MZ, Chen H-Y, Wu S-H, Peng S-W, Lee K-L, Wei P-K et al. Magnetic nanoparticle-enhanced SPR on gold nanoslits for ultra-sensitive, label-free detection of nucleic acid biomarkers. Analyst 2013; 138: 2740–2748.

    Article  CAS  Google Scholar 

  22. Van de Broek B, Frederix F, Bonroy K, Jans H, Maes G, Borghs G Shape-controlled synthesis and functionalization of gold nanoparticles for hyperthermia applications. Nanotechnology 2011; 22: 015601.

  23. Kira A, Matsuo K, Nakajima S-i . DNA hybridization activity of single-stranded DNA-conjugated gold nanoparticles used as probes for DNA detection. Jpn J Appl Phys 2015; 55: 02BE4.

    Google Scholar 

  24. Guo L, Kim D-H . LSPR biomolecular assay with high sensitivity induced by aptamer–antigen–antibody sandwich complex. Biosens Bioelectron 2012; 31: 567–570.

    Article  CAS  Google Scholar 

  25. Huang Y, Kannan P, Zhang L, Chen T, Kim D-H . Concave gold nanoparticle-based highly sensitive electrochemical IgG immunobiosensor for the detection of antibody–antigen interactions. RSC Adv 2015; 5: 58478–58484.

    Article  CAS  Google Scholar 

  26. Taguchi T, Isozaki K, Miki K . Enhanced catalytic activity of self‐assembled‐monolayer‐capped gold nanoparticles. Adv Mater 2012; 24: 6462–6467.

    Article  CAS  Google Scholar 

  27. Aćimović SS, Ortega MA, Sanz V, Berthelot J, Garcia-Cordero JL, Renger J et al. LSPR chip for parallel, rapid, and sensitive detection of cancer markers in serum. Nano Lett 2014; 14: 2636–2641.

    Article  Google Scholar 

  28. Arkan E, Saber R, Karimi Z, Mostafaie A, Shamsipur M . Multiwall carbon nanotube-ionic liquid electrode modified with gold nanoparticles as a base for preparation of a novel impedimetric immunosensor for low level detection of human serum albumin in biological fluids. J Pharm Biomed Anal 2014; 92: 74–81.

    Article  CAS  Google Scholar 

  29. Rayavarapu RG, Petersen W, Ungureanu C, Post JN, van Leeuwen TG, Manohar S . Synthesis and bioconjugation of gold nanoparticles as potential molecular probes for light-based imaging techniques. J Biomed Imaging 2007; 2007: 5.

    Google Scholar 

  30. Kumar S, Aaron J, Sokolov K . Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat Protoc 2008; 3: 314–320.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was financially supported by a research grant from Iran National Science Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M H Jazayeri.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jazayeri, M., Amani, H., Pourfatollah, A. et al. Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies. Cancer Gene Ther 23, 365–369 (2016). https://doi.org/10.1038/cgt.2016.42

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2016.42

This article is cited by

Search

Quick links